Menu
Currency
GWAS Study

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.

Urban TJ, Shen Y, Stolz A et al.

22968431 PubMed ID
GWAS Study Type
6678 Participants
41 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

UT
Urban TJ
SY
Shen Y
SA
Stolz A
CN
Chalasani N
FR
Fontana RJ
RJ
Rochon J
GD
Ge D
SK
Shianna KV
DA
Daly AK
LM
Lucena MI
NM
Nelson MR
MM
Molokhia M
AG
Aithal GP
FA
Floratos A
PI
Pe'er I
SJ
Serrano J
BH
Bonkovsky H
DT
Davern TJ
LW
Lee WM
NV
Navarro VJ
TJ
Talwalkar JA
GD
Goldstein DB
WP
Watkins PB
Chapter II

Abstract

Summary of the research findings

Background and aims: Drug-induced liver injury (DILI) is a serious adverse drug event that is suspected to have a heritable component. We carried out a genome-wide association study of 783 individuals of European ancestry who experienced DILI due to more than 200 implicated drugs.

783 European ancestry cases, 3,001 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

6678
Total Participants
GWAS
Study Type
Yes
Replicated
307 European ancestry cases, 2,587 European ancestry controls
Replication Participants
European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.